GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (FRA:3L3) » Definitions » Earnings per Share (Diluted)

Tactile Systems Technology (FRA:3L3) Earnings per Share (Diluted) : €0.59 (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Tactile Systems Technology Earnings per Share (Diluted)?

Tactile Systems Technology's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €0.19. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €0.59.

Tactile Systems Technology's EPS (Basic) for the three months ended in Sep. 2024 was €0.19. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was €0.59.

Tactile Systems Technology's EPS without NRI for the three months ended in Sep. 2024 was €0.19. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was €0.59.

During the past 12 months, Tactile Systems Technology's average EPS without NRIGrowth Rate was -33.30% per year.

During the past 11 years, Tactile Systems Technology's highest 3-Year average EPS without NRI Growth Rate was 55.10% per year. The lowest was -14.00% per year. And the median was 37.20% per year.


Tactile Systems Technology Earnings per Share (Diluted) Historical Data

The historical data trend for Tactile Systems Technology's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Earnings per Share (Diluted) Chart

Tactile Systems Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 -0.03 -0.53 -0.84 1.13

Tactile Systems Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.32 -0.08 0.17 0.19

Competitive Comparison of Tactile Systems Technology's Earnings per Share (Diluted)

For the Medical Devices subindustry, Tactile Systems Technology's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tactile Systems Technology's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's PE Ratio distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's PE Ratio falls into.



Tactile Systems Technology Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Tactile Systems Technology's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(26.148-0)/23.176
=1.13

Tactile Systems Technology's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2024 is calculated as

Diluted Earnings Per Share (Q: Sep. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(4.645-0)/24.254
=0.19

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Tactile Systems Technology  (FRA:3L3) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tactile Systems Technology Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tactile Systems Technology Business Description

Traded in Other Exchanges
Address
3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Tactile Systems Technology Headlines

No Headlines